230 related articles for article (PubMed ID: 10194435)
1. A mutation in the extracellular cysteine-rich repeat region of the beta3 subunit activates integrins alphaIIbbeta3 and alphaVbeta3.
Kashiwagi H; Tomiyama Y; Tadokoro S; Honda S; Shiraga M; Mizutani H; Handa M; Kurata Y; Matsuzawa Y; Shattil SJ
Blood; 1999 Apr; 93(8):2559-68. PubMed ID: 10194435
[TBL] [Abstract][Full Text] [Related]
2. A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.
Morel-Kopp MC; Melchior C; Chen P; Ammerlaan W; Lecompte T; Kaplan C; Kieffer N
Thromb Haemost; 2001 Dec; 86(6):1425-34. PubMed ID: 11776310
[TBL] [Abstract][Full Text] [Related]
3. Green fluorescent protein (GFP) tagged to the cytoplasmic tail of alphaIIb or beta3 allows the expression of a fully functional integrin alphaIIb(beta3): effect of beta3GFP on alphaIIb(beta3) ligand binding.
Plançon S; Morel-Kopp MC; Schaffner-Reckinger E; Chen P; Kieffer N
Biochem J; 2001 Jul; 357(Pt 2):529-36. PubMed ID: 11439104
[TBL] [Abstract][Full Text] [Related]
4. Serine 752 in the cytoplasmic domain of the beta 3 integrin subunit is not required for alpha v beta 3 postreceptor signaling events.
Kieffer N; Melchior C; Guinet JM; Michels S; Gouon V; Bron N
Cell Adhes Commun; 1996 Jul; 4(1):25-39. PubMed ID: 8870971
[TBL] [Abstract][Full Text] [Related]
5. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling.
Phillips DR; Nannizzi-Alaimo L; Prasad KS
Thromb Haemost; 2001 Jul; 86(1):246-58. PubMed ID: 11487013
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes.
Sun QH; Liu CY; Wang R; Paddock C; Newman PJ
Blood; 2002 Sep; 100(6):2094-101. PubMed ID: 12200372
[TBL] [Abstract][Full Text] [Related]
7. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation.
Chen P; Melchior C; Brons NH; Schlegel N; Caen J; Kieffer N
J Biol Chem; 2001 Oct; 276(42):38628-35. PubMed ID: 11507099
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-bound integrin-associated protein (CD47) physically and functionally modifies integrin alphaIIbbeta3 by its extracellular domain.
Fujimoto TT; Katsutani S; Shimomura T; Fujimura K
J Biol Chem; 2003 Jul; 278(29):26655-65. PubMed ID: 12736272
[TBL] [Abstract][Full Text] [Related]
9. Affinity modulation of platelet integrin alphaIIbbeta3 by beta3-endonexin, a selective binding partner of the beta3 integrin cytoplasmic tail.
Kashiwagi H; Schwartz MA; Eigenthaler M; Davis KA; Ginsberg MH; Shattil SJ
J Cell Biol; 1997 Jun; 137(6):1433-43. PubMed ID: 9182673
[TBL] [Abstract][Full Text] [Related]
10. A Leu262Pro mutation in the integrin beta(3) subunit results in an alpha(IIb)-beta(3) complex that binds fibrin but not fibrinogen.
Ward CM; Kestin AS; Newman PJ
Blood; 2000 Jul; 96(1):161-9. PubMed ID: 10891446
[TBL] [Abstract][Full Text] [Related]
11. Integrin-mediated activation of focal adhesion kinase is independent of focal adhesion formation or integrin activation. Studies with activated and inhibitory beta3 cytoplasmic domain mutants.
Lyman S; Gilmore A; Burridge K; Gidwitz S; White GC
J Biol Chem; 1997 Sep; 272(36):22538-47. PubMed ID: 9278407
[TBL] [Abstract][Full Text] [Related]
12. Distinct domains of alphaIIbbeta3 support different aspects of outside-in signal transduction and platelet activation induced by LSARLAF, an alphaIIbbeta3 interacting peptide.
Derrick JM; Shattil SJ; Poncz M; Gruppo RA; Gartner TK
Thromb Haemost; 2001 Sep; 86(3):894-901. PubMed ID: 11583324
[TBL] [Abstract][Full Text] [Related]
13. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.
Ruiz C; Liu CY; Sun QH; Sigaud-Fiks M; Fressinaud E; Muller JY; Nurden P; Nurden AT; Newman PJ; Valentin N
Blood; 2001 Oct; 98(8):2432-41. PubMed ID: 11588040
[TBL] [Abstract][Full Text] [Related]
14. Beta3 integrin activation improves alphavbeta3-mediated retraction of fibrin matrices.
Corbett SA; Schwarzbauer JE
J Surg Res; 1999 May; 83(1):27-31. PubMed ID: 10210638
[TBL] [Abstract][Full Text] [Related]
15. The novel S527F mutation in the integrin beta3 chain induces a high affinity alphaIIbbeta3 receptor by hindering adoption of the bent conformation.
Vanhoorelbeke K; De Meyer SF; Pareyn I; Melchior C; Plançon S; Margue C; Pradier O; Fondu P; Kieffer N; Springer TA; Deckmyn H
J Biol Chem; 2009 May; 284(22):14914-20. PubMed ID: 19329429
[TBL] [Abstract][Full Text] [Related]
16. A molecular basis for affinity modulation of Fab ligand binding to integrin alphaIIb beta3.
Kunicki TJ; Annis DS; Deng YJ; Loftus JC; Shattil SJ
J Biol Chem; 1996 Aug; 271(34):20315-21. PubMed ID: 8702765
[TBL] [Abstract][Full Text] [Related]
17. Divalent cations differentially regulate integrin alphaIIb cytoplasmic tail binding to beta3 and to calcium- and integrin-binding protein.
Vallar L; Melchior C; Plançon S; Drobecq H; Lippens G; Regnault V; Kieffer N
J Biol Chem; 1999 Jun; 274(24):17257-66. PubMed ID: 10358085
[TBL] [Abstract][Full Text] [Related]
18. Membrane-proximal {alpha}/{beta} stalk interactions differentially regulate integrin activation.
Kamata T; Handa M; Sato Y; Ikeda Y; Aiso S
J Biol Chem; 2005 Jul; 280(26):24775-83. PubMed ID: 15863495
[TBL] [Abstract][Full Text] [Related]
19. Role of the alpha-subunit 326GRV sequence in the surface expression of fibrinogen and vitronectin receptors.
Ferrer M; Ayuso MS; Butta N; Parrilla R; González-Manchón C
Am J Physiol; 1998 Nov; 275(5):C1239-46. PubMed ID: 9814972
[TBL] [Abstract][Full Text] [Related]
20. A variant thrombasthenic phenotype associated with compound heterozygosity of integrin beta3-subunit: (Met124Val)beta3 alters the subunit dimerization rendering a decreased number of constitutive active alphaIIbbeta3 receptors.
González-Manchón C; Butta N; Larrucea S; Arias-Salgado EG; Alonso S; López A; Parrilla R
Thromb Haemost; 2004 Dec; 92(6):1377-86. PubMed ID: 15583747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
